We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 29 JUNE 2012
Eli Lilly Suggests Bright-Line Rule In Myriad Amicus Brief
Foley & Lardner LLP
Eli Lilly filed an interesting amicus brief in the remand of Association for Molecular Pathology v. Myriad Genetics, Inc. (the ACLU "gene patenting"/BRCAI case).
United StatesIntellectual Property








